Developer docs
API playgroundTry for free, no card

Search company profiles

Vivid Vision

Full company profile

uuid00028mw

Namestring
Vivid Vision
Legal namestring
Vivid Vision, Inc.
Websiteurl
seevividly.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Vivid Vision is a privately-held digital health company founded in 2014 and headquartered in San Francisco, with a wholly-owned subsidiary in Tokyo (Vivid Vision Asia, Inc.). The company develops a VR-based vision care platform with three core products: Vivid Vision Clinical (in-office VR training for licensed eye care professionals), Vivid Vision Home (prescribed at-home VR therapy), and Vivid Vision Perimetry (VVP), an ultra-precise VR-based visual field testing system used as a digital endpoint in ophthalmic clinical trials for geographic atrophy, AMD, and glaucoma. Underlying technology uses head-mounted displays with dichoptic stimulation for binocular vision therapy and natural-fixation perimetry with lesion-customized stimulus placement for retinal assessment, achieving 6.8x better precision than Standard Automated Perimetry.

The business model is a B2B provider-network model with two distinct revenue streams. In the clinical vertical, Vivid Vision licenses software subscriptions to licensed optometrists, ophthalmologists, and vision therapy clinics who prescribe treatment to patients; patients typically pay providers $700-$1,200 per 3-month program, with Vivid Vision capturing a software licensing slice. The company also sells DPVR P1 Pro VR headsets (with Vivid Vision Home pre-installed) exclusively to providers through its online store. Distribution is direct in the US with regional resellers in the EU/UK (VISUS), Mexico (optirepresentaciones), and Asia. In the biopharma vertical, Vivid Vision sells VVP as a clinical-trial endpoint service to large ophthalmic pharmaceutical companies, anchored by a Regeneron-sponsored validation study at the Retina Foundation of the Southwest. As of 2025, the company reports 100,000+ patients treated across 50+ countries, FDA Class I medical device registration, CE Mark certification, and HIPAA/GDPR compliance.

Short descriptiontext

Vivid Vision develops VR-based vision care software for treating binocular vision disorders (amblyopia, strabismus, convergence insufficiency) and provides clinical-trial-grade visual field testing endpoints for ophthalmic pharmaceutical companies. Sold through a global network of licensed eye care professionals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
VR vision therapy, binocular vision treatment, visual field testing, clinical trial endpoints, dichoptic vision training
Industry1 code
PRIMARYMPAFAGAG
VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics)
Media, Entertainment & Sports/Gaming & Interactive Entertainment (Video Games, Esports)/Gaming Hardware & Peripherals (Consoles, PCs, Controllers, VR)
NAICS code1 code
  • Ophthalmic Goods Manufacturing339115
SIC code1 code
  • Ophthalmic Goods3851
Product category
VR-based vision therapy software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Software Subscriptions (Clinical)
TypeSubscription Recurring
Description

Vivid Vision Clinical software licensed to eye care professionals for in-office treatment. Requires active provider account and is sold through direct sales and distributor networks. Pricing varies by geographic location, provider experience, and treatment plan complexity.

cn.seevividly.com
2Software Subscriptions (Home)
TypeSubscription Recurring
Description

Vivid Vision Home software prescribed by providers to patients for at-home vision therapy exercises. Sold in license pools to providers who then manage patient access. Patients pay through their vision therapy program costs ($700-$1200 for 3 months per patient reports).

cn.seevividly.com
3Hardware Sales
TypeHardware Sales
Description

VR headsets sold through Vivid Vision online store. Commercial-grade DPVR P1 Pro headset comes pre-installed with Vivid Vision Home software and is available exclusively to providers, not consumers.

cn.seevividly.com
4EYEBAB VT Distribution
TypeLicensing Royalties
Description

Distribution partnership for EYEBAB vision therapy software in USA and Canada, bringing in additional software licensing revenue through Vivid Vision's provider network.

cn.seevividly.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Vivid Vision Clinical - In-office treatment system
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Pricing varies by region and provider. Requires active provider account with the company. The Clinical system is more powerful and treats a larger range of binocular vision conditions than Home.

cn.seevividly.com
2Vivid Vision Home - At-home vision therapy
ModelSubscriptionBilling cadenceMonthly
Notes

Licenses sold in pools to providers who assign to patients. Patients report costs ranging from $700-$1200 for 3-month programs. Providers can offer auto-renew licenses. Some clinics include Vivid Vision as part of comprehensive vision therapy programs.

cn.seevividly.com
3VR Hardware (DPVR P1 Pro)
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

DPVR headset pre-loaded with Vivid Vision Home is available to providers only through Vivid Vision's online store. Recommended mobile headset for patients. No Facebook account required. Not available directly to consumers.

cn.seevividly.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Vivid Vision Perimetry (VVP)
Description

Ultra-precise visual field testing solution for clinical trials, used for AMD, GA, and glaucoma endpoints

seevividly.com
+3 more records
Core offering1 text field

Vivid Vision develops VR-based software for vision care, sold to licensed eye care professionals for in-office and at-home treatment of amblyopia, strabismus, and convergence insufficiency, plus clinical-grade VR perimetry used as endpoints in ophthalmic clinical trials. The company licenses its Vivid Vision Clinical and Vivid Vision Home platforms to providers, distributes pre-configured VR headsets, and operates a provider network across 50+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 6.8x better precision than Standard Automated Perimetry (SAP)
+4 more records
Product overview1 text field

Vivid Vision offers a suite of VR-based vision care products consisting of Vivid Vision Clinical (in-office vision training system for eye care professionals), Vivid Vision Home (prescribed at-home vision therapy via web application), and Vivid Vision Perimetry (VR-based perimetry for clinical trials). The company also distributes EYEBAB VT as a supplementary vision therapy module. Vivid Vision treats conditions including amblyopia, strabismus, and convergence insufficiency using dichoptic VR technology that presents different images to each eye to train binocular vision.

Product and service6 records
1Vivid Vision Clinical
CategoryVision therapy software
Description

In-office vision training system for licensed eye care professionals (optometrists and ophthalmologists) that uses VR to assess and treat amblyopia, strabismus, convergence insufficiency, and other binocular vision disorders with room-scale VR exercises and sports vision training.

2Vivid Vision Home
CategoryVision therapy software
Description

Web-based at-home vision therapy application prescribed by licensed eye care providers, allowing patients to perform dichoptic VR therapy exercises on their own schedule from home using compatible VR headsets.

3Vivid Vision Perimetry (VVP)
CategoryClinical trial diagnostic software
Description

Ultra-precise VR-based visual field testing system with natural fixation and lesion-customized stimulus grids, used as a targeted microperimetry endpoint in clinical trials for geographic atrophy, AMD, and glaucoma. Provides 6.8x better precision than standard automated perimetry.

4EYEBAB VT
CategoryVision therapy software (third-party distributed)
Description

Vision therapy software distributed by Vivid Vision in US and Canada offering dozens of vision activities and visual processing exercises including consensus, reaction time, concentration, endurance, and memory training for post-concussion and vision rehabilitation.

5Vivid Vision Perimetry Digital Endpoints
CategoryClinical trial endpoint services
Description

Targeted microperimetry-based digital endpoints used in clinical trials for geographic atrophy, AMD, and glaucoma, providing 6.8x better precision than SAP and 2x better fixation stability, accelerating pharmaceutical trial timelines.

6DPVR P1 Pro VR Headset
CategoryVR hardware
Description

Commercial-grade VR headset pre-installed with Vivid Vision Home software, sold exclusively to licensed providers through the Vivid Vision online store as the recommended headset for patient home use.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-09-18
Description

Vivid Vision selected as finalist for VSP Vision Innovation Challenge 2025, a global competition hosted by VSP Vision, MATTER healthcare incubator, and Topcon Healthcare. Chief Growth Officer Kelin Kushin presented the company's solution at Vision Expo West. The partnership provides mentorship, industry connections, and market exposure within the vision care ecosystem.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-12
Description

Regeneron sponsored the landmark study by Dr. Karl Csaky at Retina Foundation of the Southwest demonstrating that at-home VR-based vision testing matches the accuracy of in-clinic microperimetry while providing greater precision. The study validated Vivid Vision Perimetry for use in geographic atrophy clinical trials.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-11-26
Description

Distribution agreement signed November 26, 2020 for EYEBAB vision therapy software in USA and Canada. EYEBAB specializes in digital vision training apps for people with vision and concentration difficulties, including post-concussion rehabilitation. Vivid Vision's large professional network distributes EYEBAB's platform, which includes training for consensus, reaction time, concentration, endurance, and memory.

Strategic tierMinorTypeGTM or Marketing Partner
Description

MATTER provided expert mentorship, pitch deck support, and exclusive resources during the four-week startup bootcamp as part of the VSP Innovation Challenge 2025.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Co-host of the VSP Vision Innovation Challenge 2025, providing industry expertise and connections within the vision care technology space.

6Retina Foundation of the Southwest
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Premier research institution led by Dr. Karl Csaky that conducted the pivotal study validating Vivid Vision Perimetry. The foundation was the first site to evaluate VVP tests in patients with Geographic Atrophy and presented findings at Macula Society.

seevividly.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Eleonora Lad, MD, PhD, Vice Chair of Clinical Research, Ophthalmology, serves as a key opinion leader endorsing Vivid Vision Perimetry as an endpoint in clinical trials for bringing sight-saving therapeutics to market.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1AmblyoPlay
TypeEmerging player
Description

AmblyoPlay provides gamified at-home vision therapy software for amblyopia and other binocular conditions, competing with Vivid Vision Home on patient-facing, prescribed vision therapy programs.

TypeBroad incumbent
Description

Topcon Healthcare is a major incumbent in ophthalmic diagnostic imaging and perimetry (e.g., MAIA microperimetry), making it both a potential competitor and partner in the retinal clinical-trial endpoint space where Vivid Vision Perimetry competes.

TypeDirect peer
Description

Luminopia develops FDA-cleared dichoptic VR therapy for amblyopia in children and is a direct competitor to Vivid Vision, including head-to-head testing in the NIH-funded PEDIG pediatric amblyopia trials. Both companies target the same patient population and provider channel with VR-based binocular vision therapy.

TypeDirect peer
Description

CureSight (by NovaSight) provides at-home digital vision therapy for amblyopia using eye-tracking and binocular training, directly overlapping with Vivid Vision Home on patient use cases and provider prescription workflows.

5Carl Zeiss Meditec
TypeBroad incumbent
Description

Zeiss Meditec manufactures Humphrey Field Analyzers, the dominant standard automated perimetry (SAP) devices that VVP benchmarks against. As the incumbent in visual field testing, it represents the primary technology competitor for the perimetry business.

TypeBroad incumbent
Description

Haag-Streit manufactures ophthalmic diagnostic equipment including perimetry devices used in eye care practices, making it an adjacent incumbent in the visual field testing market that Vivid Vision Perimetry targets.

TypeOthers
Description

DPVR is the VR headset manufacturer whose DPVR P1 Pro is sold pre-loaded with Vivid Vision Home through Vivid Vision's online store, making it a key hardware partner and ecosystem dependency for the home therapy product.

TypeDirect peer
Description

NovaSight offers eye-tracking-based digital vision therapies and diagnostics, including amblyopia treatment products that compete with Vivid Vision Clinical and Home. It targets the same optometrist/ophthalmologist provider base with VR/AI-based pediatric vision solutions.

9Bynocs
TypeEmerging player
Description

Bynocs offers cloud-based binocular vision therapy software used by optometrists for amblyopia, strabismus, and vergence disorders, with a clinical B2B model similar to Vivid Vision Clinical but delivered via screen-based rather than fully immersive VR.

TypeEmerging player
Description

RevitaVision provides office-based and home-based vision therapy software for binocular vision disorders, addressing the same optometric practice channel as Vivid Vision Clinical with an alternative digital workflow.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vivid Vision

VR-based vision therapy softwareseevividly.com

Vivid Vision develops VR-based vision care software for treating binocular vision disorders (amblyopia, strabismus, convergence insufficiency) and provides clinical-trial-grade visual field testing endpoints for ophthalmic pharmaceutical companies. Sold through a global network of licensed eye care professionals.

What Vivid Vision does

Vivid Vision is a privately-held digital health company founded in 2014 and headquartered in San Francisco, with a wholly-owned subsidiary in Tokyo (Vivid Vision Asia, Inc.). The company develops a VR-based vision care platform with three core products: Vivid Vision Clinical (in-office VR training for licensed eye care professionals), Vivid Vision Home (prescribed at-home VR therapy), and Vivid Vision Perimetry (VVP), an ultra-precise VR-based visual field testing system used as a digital endpoint in ophthalmic clinical trials for geographic atrophy, AMD, and glaucoma. Underlying technology uses head-mounted displays with dichoptic stimulation for binocular vision therapy and natural-fixation perimetry with lesion-customized stimulus placement for retinal assessment, achieving 6.8x better precision than Standard Automated Perimetry.

The business model is a B2B provider-network model with two distinct revenue streams. In the clinical vertical, Vivid Vision licenses software subscriptions to licensed optometrists, ophthalmologists, and vision therapy clinics who prescribe treatment to patients; patients typically pay providers $700-$1,200 per 3-month program, with Vivid Vision capturing a software licensing slice. The company also sells DPVR P1 Pro VR headsets (with Vivid Vision Home pre-installed) exclusively to providers through its online store. Distribution is direct in the US with regional resellers in the EU/UK (VISUS), Mexico (optirepresentaciones), and Asia. In the biopharma vertical, Vivid Vision sells VVP as a clinical-trial endpoint service to large ophthalmic pharmaceutical companies, anchored by a Regeneron-sponsored validation study at the Retina Foundation of the Southwest. As of 2025, the company reports 100,000+ patients treated across 50+ countries, FDA Class I medical device registration, CE Mark certification, and HIPAA/GDPR compliance.

Vivid Vision firmographics

Firmographics
Name
Vivid Vision
Legal name
Vivid Vision, Inc.
Website
https://seevividly.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
Vivid Vision develops VR-based vision care software for treating binocular vision disorders (amblyopia, strabismus, convergence insufficiency) and provides clinical-trial-grade visual field testing endpoints for ophthalmic pharmaceutical companies. Sold through a global network of licensed eye care professionals.
Ownership category
akta.pro rank

Vivid Vision industry classification

Industry
Product category
VR-based vision therapy software
NAICS
Ophthalmic Goods Manufacturing (339115)
SIC
Ophthalmic Goods (3851)
akta.pro industry
PRIMARYMPAFAGAG
VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics)
Media, Entertainment & Sports/Gaming & Interactive Entertainment (Video Games, Esports)/Gaming Hardware & Peripherals (Consoles, PCs, Controllers, VR)

Keywords

  • VR vision therapy
  • Binocular vision treatment
  • Visual field testing
  • Clinical trial endpoints
  • Dichoptic vision training

Where Vivid Vision is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Vivid Vision business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Subscriptions (Clinical): Vivid Vision Clinical software licensed to eye care professionals for in-office treatment. Requires active provider account and is sold through direct sales and distributor networks. Pricing varies by geographic location, provider experience, and treatment plan complexity.
  2. Software Subscriptions (Home): Vivid Vision Home software prescribed by providers to patients for at-home vision therapy exercises. Sold in license pools to providers who then manage patient access. Patients pay through their vision therapy program costs ($700-$1200 for 3 months per patient reports).
  3. Hardware Sales: VR headsets sold through Vivid Vision online store. Commercial-grade DPVR P1 Pro headset comes pre-installed with Vivid Vision Home software and is available exclusively to providers, not consumers.
  4. EYEBAB VT Distribution: Distribution partnership for EYEBAB vision therapy software in USA and Canada, bringing in additional software licensing revenue through Vivid Vision's provider network.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractVivid Vision Clinical - In-office treatment system
SubscriptionMonthlyVivid Vision Home - At-home vision therapy
One time/ perpetual licenseOne time/ perpetual licenseVR Hardware (DPVR P1 Pro)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Vivid Vision product offering

Product offering

Core offering

Vivid Vision develops VR-based software for vision care, sold to licensed eye care professionals for in-office and at-home treatment of amblyopia, strabismus, and convergence insufficiency, plus clinical-grade VR perimetry used as endpoints in ophthalmic clinical trials. The company licenses its Vivid Vision Clinical and Vivid Vision Home platforms to providers, distributes pre-configured VR headsets, and operates a provider network across 50+ countries.

Product overview

Vivid Vision offers a suite of VR-based vision care products consisting of Vivid Vision Clinical (in-office vision training system for eye care professionals), Vivid Vision Home (prescribed at-home vision therapy via web application), and Vivid Vision Perimetry (VR-based perimetry for clinical trials). The company also distributes EYEBAB VT as a supplementary vision therapy module. Vivid Vision treats conditions including amblyopia, strabismus, and convergence insufficiency using dichoptic VR technology that presents different images to each eye to train binocular vision.

Differentiator

Problem solved

Functional benefit

Brands

  • Vivid Vision Perimetry (VVP): Ultra-precise visual field testing solution for clinical trials, used for AMD, GA, and glaucoma endpoints
  • EYEBAB VT
  • Vivid Vision Clinical
  • Vivid Vision Home

Products and services

  • Vivid Vision Clinical In-office vision training system for licensed eye care professionals (optometrists and ophthalmologists) that uses VR to assess and treat amblyopia, strabismus, convergence insufficiency, and other binocular vision disorders with room-scale VR exercises and sports vision training.
  • Vivid Vision Home Web-based at-home vision therapy application prescribed by licensed eye care providers, allowing patients to perform dichoptic VR therapy exercises on their own schedule from home using compatible VR headsets.
  • Vivid Vision Perimetry (VVP) Ultra-precise VR-based visual field testing system with natural fixation and lesion-customized stimulus grids, used as a targeted microperimetry endpoint in clinical trials for geographic atrophy, AMD, and glaucoma. Provides 6.8x better precision than standard automated perimetry.
  • EYEBAB VT Vision therapy software distributed by Vivid Vision in US and Canada offering dozens of vision activities and visual processing exercises including consensus, reaction time, concentration, endurance, and memory training for post-concussion and vision rehabilitation.
  • Vivid Vision Perimetry Digital Endpoints Targeted microperimetry-based digital endpoints used in clinical trials for geographic atrophy, AMD, and glaucoma, providing 6.8x better precision than SAP and 2x better fixation stability, accelerating pharmaceutical trial timelines.
  • DPVR P1 Pro VR Headset Commercial-grade VR headset pre-installed with Vivid Vision Home software, sold exclusively to licensed providers through the Vivid Vision online store as the recommended headset for patient home use.

Quantifiable outcome

  • 6.8x better precision than Standard Automated Perimetry (SAP)
  • +4 more outcomes

Companies that use Vivid Vision

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Vivid Vision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Vivid Vision partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • VSP VisioncoreGTM or Marketing Partner · 18 September 2025Vivid Vision selected as finalist for VSP Vision Innovation Challenge 2025, a global competition hosted by VSP Vision, MATTER healthcare incubator, and Topcon Healthcare. Chief Growth Officer Kelin Kushin presented the company's solution at Vision Expo West. The partnership provides mentorship, industry connections, and market exposure within the vision care ecosystem.
  • RegeneroncoreStrategic or Co-development Partner · 12 February 2025Regeneron sponsored the landmark study by Dr. Karl Csaky at Retina Foundation of the Southwest demonstrating that at-home VR-based vision testing matches the accuracy of in-clinic microperimetry while providing greater precision. The study validated Vivid Vision Perimetry for use in geographic atrophy clinical trials.
  • EYEBAB ApScoreChannel Partner/ Reseller/ Distributor · 26 November 2020Distribution agreement signed November 26, 2020 for EYEBAB vision therapy software in USA and Canada. EYEBAB specializes in digital vision training apps for people with vision and concentration difficulties, including post-concussion rehabilitation. Vivid Vision's large professional network distributes EYEBAB's platform, which includes training for consensus, reaction time, concentration, endurance, and memory.
  • MATTER Healthcare IncubatorminorGTM or Marketing PartnerMATTER provided expert mentorship, pitch deck support, and exclusive resources during the four-week startup bootcamp as part of the VSP Innovation Challenge 2025.
  • Topcon HealthcareminorGTM or Marketing PartnerCo-host of the VSP Vision Innovation Challenge 2025, providing industry expertise and connections within the vision care technology space.
  • Retina Foundation of the SouthwestcoreStrategic or Co-development PartnerPremier research institution led by Dr. Karl Csaky that conducted the pivotal study validating Vivid Vision Perimetry. The foundation was the first site to evaluate VVP tests in patients with Geographic Atrophy and presented findings at Macula Society.
  • Duke University Medical CenterminorStrategic or Co-development PartnerDr. Eleonora Lad, MD, PhD, Vice Chair of Clinical Research, Ophthalmology, serves as a key opinion leader endorsing Vivid Vision Perimetry as an endpoint in clinical trials for bringing sight-saving therapeutics to market.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Vivid Vision competitors and assessment

Company assessment

Emerging players

  • AmblyoPlay: AmblyoPlay provides gamified at-home vision therapy software for amblyopia and other binocular conditions, competing with Vivid Vision Home on patient-facing, prescribed vision therapy programs.
  • Bynocs: Bynocs offers cloud-based binocular vision therapy software used by optometrists for amblyopia, strabismus, and vergence disorders, with a clinical B2B model similar to Vivid Vision Clinical but delivered via screen-based rather than fully immersive VR.
  • RevitaVision: RevitaVision provides office-based and home-based vision therapy software for binocular vision disorders, addressing the same optometric practice channel as Vivid Vision Clinical with an alternative digital workflow.

Broad incumbents

  • Topcon Healthcare: Topcon Healthcare is a major incumbent in ophthalmic diagnostic imaging and perimetry (e.g., MAIA microperimetry), making it both a potential competitor and partner in the retinal clinical-trial endpoint space where Vivid Vision Perimetry competes.
  • Carl Zeiss Meditec: Zeiss Meditec manufactures Humphrey Field Analyzers, the dominant standard automated perimetry (SAP) devices that VVP benchmarks against. As the incumbent in visual field testing, it represents the primary technology competitor for the perimetry business.
  • Haag-Streit: Haag-Streit manufactures ophthalmic diagnostic equipment including perimetry devices used in eye care practices, making it an adjacent incumbent in the visual field testing market that Vivid Vision Perimetry targets.

Direct peers

  • Luminopia: Luminopia develops FDA-cleared dichoptic VR therapy for amblyopia in children and is a direct competitor to Vivid Vision, including head-to-head testing in the NIH-funded PEDIG pediatric amblyopia trials. Both companies target the same patient population and provider channel with VR-based binocular vision therapy.
  • CureSight: CureSight (by NovaSight) provides at-home digital vision therapy for amblyopia using eye-tracking and binocular training, directly overlapping with Vivid Vision Home on patient use cases and provider prescription workflows.
  • NovaSight: NovaSight offers eye-tracking-based digital vision therapies and diagnostics, including amblyopia treatment products that compete with Vivid Vision Clinical and Home. It targets the same optometrist/ophthalmologist provider base with VR/AI-based pediatric vision solutions.

Others

  • DPVR: DPVR is the VR headset manufacturer whose DPVR P1 Pro is sold pre-loaded with Vivid Vision Home through Vivid Vision's online store, making it a key hardware partner and ecosystem dependency for the home therapy product.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Vivid Vision social profiles

Digital presence

Vivid Vision compliance and trust

Trust signal

Compliance5 records

Vivid Vision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vivid Vision leadership team

Management profile

Number of profiles

Profiles5 records

Vivid Vision subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Vivid Vision funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vivid Vision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivid Vision

What does Vivid Vision do?

Vivid Vision develops VR-based software for vision care, sold to licensed eye care professionals for in-office and at-home treatment of amblyopia, strabismus, and convergence insufficiency, plus clinical-grade VR perimetry used as endpoints in ophthalmic clinical trials. The company licenses its Vivid Vision Clinical and Vivid Vision Home platforms to providers, distributes pre-configured VR headsets, and operates a provider network across 50+ countries.

Is Vivid Vision a public or private company?

Vivid Vision is a private company. It is classified as venture growth investor backed and is currently operating.

When was Vivid Vision founded?

Vivid Vision was founded in 2014. It employs 51 to 100 people.

Where is Vivid Vision based?

Vivid Vision is headquartered in San Francisco, United States, in the North America region.

How does Vivid Vision make money?

Four revenue lines are on record. Software Subscriptions (Clinical) is the primary driver. The others are software Subscriptions (Home), hardware Sales and EYEBAB VT Distribution.

Who are Vivid Vision's main competitors?

Emerging players on record are AmblyoPlay, Bynocs and RevitaVision. Broad incumbents are Topcon Healthcare, Carl Zeiss Meditec and Haag-Streit. Direct peers are Luminopia, CureSight and NovaSight. DPVR is listed as an others.

Does Vivid Vision have an API?

No public API is recorded for Vivid Vision.

What industry is Vivid Vision in?

Vivid Vision's product category is VR-based vision therapy software. Its primary akta.pro industry code is MPAFAGAG, VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics). Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cleveland ClinicReal-World Evidence Supports Dichoptic Therapy for AmblyopiaDr. Alexandra Williamson of Cleveland Clinic Cole Eye Institute presented research at the 2025 American Academy of Optometry meeting showing that Luminopia dichoptic therapy produces statistically significant real-world visual acuity improvements in amblyopia patients, including those with severe vision loss (BCVA of 20/100 or worse). The registry-based study of 59 patients found an average improvement of 1.8 lines in best-corrected visual acuity, with treatment-naïve patients showing greater gains (3.8 lines) than those with prior treatment history (1.5 lines). New clinical guidelines are in development as evidence accumulates from ongoing trials and real-world studies of dichoptic therapies including CureSight and Vivid Vision.LinkedInVision Therapy Software Market Demand Evolution | AI & Digital InnovationGlobalVista Analytics Pro, a research firm under Verified Market Reports, published a market analysis forecasting the global vision therapy software sector to grow from USD 1.2 billion in 2024 to USD 3.8 billion by 2033 at a CAGR of 15.3%. The report highlights that growth is driven by AI integration, telehealth adoption, and increasing prevalence of visual disorders like amblyopia and strabismus. Key industry players such as Vivid Vision, RevitalVision, and AmblyoPlay are expanding product lines and forming partnerships to capture market share across regions including North America, Europe, and Asia Pacific.openPR.comTop Companies in the Amblyopia Treatment Market - NovaSight, Vivid Vision, AmblyoCare, RevitalVision, Orbis InternationalLeading amblyopia treatment companies including NovaSight, Vivid Vision, and AmblyoCare are profiled with their digital and VR-based strategies. The market is shifting toward integrated, technology-enabled therapeutic ecosystems, with investment flowing into VR therapies, neuroplasticity-driven approaches, and regional expansion in Asia-Pacific and Latin America.ReviewedHome-Based Visual Field Monitoring Devices in Glaucoma Management: A Review of Current Evidence and Barriers to AdoptionThis narrative review analyzes current evidence on home-based visual field monitoring devices for glaucoma management, comparing their efficacy and reliability against standard clinic-based perimetry. The article highlights technologies such as Melbourne Rapid Fields (MRF), Eyecatcher, and Vivid Vision Perimetry, noting their potential to improve early detection and reduce healthcare burdens despite challenges in patient adherence and data integration.UndTeam focuses on new vision for amblyopia (lazy eye) treatmentUND researchers in Grand Forks are recruiting families for two PEDIG clinical trials testing virtual reality-based amblyopia (lazy eye) treatment in children, representing the only clinical site selected in North Dakota. The studies, funded by the National Eye Institute/NIH and involving over 400 pediatric eye centers across North America, will compare dichoptic VR headsets (Luminopia and Vivid Vision) against traditional eye patch therapy in approximately 250 children per trial across two age groups. Researchers say the trials could change the standard of care for the first time in nearly 3,000 years, potentially improving treatment compliance and outcomes for a condition affecting 2-5 percent of the pediatric population.UbergizmoVivid Vision Creates VR Tools To Help Treat ‘Lazy Eye’Vivid Vision, a startup developing VR tools for treating lazy eye, has expanded its reach to approximately 90 clinics in the US, serving over 6,000 patients. The company recently raised $2.2 million in seed funding and plans to launch a home-based version of its treatment system to allow self-administered therapy.Road to VREye Doctors Can Now Prescribe VR Lazy-eye Treatment for Home UseVivid Vision announced a new home-use offering for its VR-based lazy eye treatment, extending its clinical service model beyond in-office settings. The optometrist-prescribed software allows patients to undergo therapy using standard VR headsets at home, with doctors able to remotely monitor progress.Road to VRVR-based Treatment for Vision Disorders Shows Positive Results in Peer-reviewed StudyA peer-reviewed study published in the BioMed Journal of Ophthalmology reports positive preliminary results for Vivid Vision's virtual reality treatment for adult amblyopia. The trial involving 17 subjects demonstrated that over 90% developed measurable stereoscopic vision after eight sessions, significantly improving upon pre-treatment metrics. These findings suggest VR-based dichoptic training may offer a more effective and engaging alternative to traditional penalizing therapies like eye patches.VC News DailyVivid Vision Raises $2.2M in Seed RoundVivid Vision has raised $2.2 million in a seed round from investors including SoftTech VC, The Venture Reality Fund, CRCM Ventures, SOS Ventures, Anorak Ventures, and Liquid 2 Ventures. The company develops eye treatment systems including Vivid Vision Clinical, described as an advanced lazy eye treatment system, and Vivid Vision Home for at-home treatment. The funding will support the company's operations in developing and commercializing its vision treatment technology.FinSMEsVivid Vision Raises $2.2M in FundingVivid Vision, a San Francisco-based virtual reality vision care company, raised €2.2M in seed funding led by Jeff Clavier from SoftTech VC. The funds will expand its vision care platform, which is used in 90 clinics worldwide with over 6,000 patients treated.